Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilon Health, Inc. stock logo
AGL
Agilon Health
$2.32
+6.2%
$2.80
$1.50
$7.73
$902.41M0.144.96 million shs2.68 million shs
Encompass Health Corporation stock logo
EHC
Encompass Health
$121.54
+0.7%
$117.22
$82.74
$123.13
$12.16B0.89700,822 shs627,895 shs
Exelixis, Inc. stock logo
EXEL
Exelixis
$43.09
-1.0%
$40.92
$21.82
$49.62
$11.87B0.282.44 million shs2.69 million shs
Select Medical Holdings Corporation stock logo
SEM
Select Medical
$15.01
+0.7%
$15.44
$14.03
$40.98
$1.92B1.34979,578 shs1.48 million shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilon Health, Inc. stock logo
AGL
Agilon Health
+5.71%+6.78%+3.35%-48.37%-64.66%
Encompass Health Corporation stock logo
EHC
Encompass Health
+0.81%+1.39%+0.46%+20.64%+43.67%
Exelixis, Inc. stock logo
EXEL
Exelixis
-1.01%+5.77%0.00%+17.41%+92.54%
Select Medical Holdings Corporation stock logo
SEM
Select Medical
+0.46%+0.51%+0.95%-10.70%-55.66%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agilon Health, Inc. stock logo
AGL
Agilon Health
3.3609 of 5 stars
4.14.00.00.03.80.00.6
Encompass Health Corporation stock logo
EHC
Encompass Health
4.8014 of 5 stars
2.65.01.75.02.52.51.9
Exelixis, Inc. stock logo
EXEL
Exelixis
4.7044 of 5 stars
2.32.00.04.32.72.54.4
Select Medical Holdings Corporation stock logo
SEM
Select Medical
4.9985 of 5 stars
3.43.02.54.82.44.25.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilon Health, Inc. stock logo
AGL
Agilon Health
2.17
Hold$4.79106.73% Upside
Encompass Health Corporation stock logo
EHC
Encompass Health
3.22
Buy$127.004.49% Upside
Exelixis, Inc. stock logo
EXEL
Exelixis
2.52
Moderate Buy$43.220.31% Upside
Select Medical Holdings Corporation stock logo
SEM
Select Medical
2.80
Moderate Buy$26.0073.18% Upside

Current Analyst Ratings Breakdown

Latest EHC, SEM, EXEL, and AGL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/24/2025
Exelixis, Inc. stock logo
EXEL
Exelixis
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$50.00
6/24/2025
Exelixis, Inc. stock logo
EXEL
Exelixis
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$29.00 ➝ $60.00
6/23/2025
Exelixis, Inc. stock logo
EXEL
Exelixis
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
6/23/2025
Exelixis, Inc. stock logo
EXEL
Exelixis
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$43.00 ➝ $55.00
6/23/2025
Exelixis, Inc. stock logo
EXEL
Exelixis
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Outperform ➝ Market Outperform$47.00 ➝ $50.00
6/12/2025
Exelixis, Inc. stock logo
EXEL
Exelixis
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$40.00 ➝ $47.00
6/5/2025
Encompass Health Corporation stock logo
EHC
Encompass Health
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeOverweight ➝ Strong-Buy$135.00
6/5/2025
Exelixis, Inc. stock logo
EXEL
Exelixis
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$45.00 ➝ $46.00
5/27/2025
Encompass Health Corporation stock logo
EHC
Encompass Health
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$122.00 ➝ $135.00
5/15/2025
Exelixis, Inc. stock logo
EXEL
Exelixis
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$45.00
5/15/2025
Exelixis, Inc. stock logo
EXEL
Exelixis
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$45.00 ➝ $56.00
(Data available from 6/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilon Health, Inc. stock logo
AGL
Agilon Health
$6.06B0.16N/AN/A$1.14 per share2.03
Encompass Health Corporation stock logo
EHC
Encompass Health
$5.37B2.28$7.62 per share15.96$27.72 per share4.38
Exelixis, Inc. stock logo
EXEL
Exelixis
$2.17B5.42$1.91 per share22.60$7.86 per share5.48
Select Medical Holdings Corporation stock logo
SEM
Select Medical
$5.19B0.37$2.52 per share5.95$15.35 per share0.98
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilon Health, Inc. stock logo
AGL
Agilon Health
-$260.15M-$0.59N/AN/AN/A-4.04%-45.47%-12.76%8/5/2025 (Estimated)
Encompass Health Corporation stock logo
EHC
Encompass Health
$455.70M$4.8425.1123.022.458.97%17.63%7.33%8/4/2025 (Estimated)
Exelixis, Inc. stock logo
EXEL
Exelixis
$521.27M$2.2019.5916.900.8727.99%28.81%21.94%8/5/2025 (Estimated)
Select Medical Holdings Corporation stock logo
SEM
Select Medical
$214.04M$1.3411.2010.650.792.81%11.04%3.25%7/30/2025 (Estimated)

Latest EHC, SEM, EXEL, and AGL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q1 2025
Agilon Health, Inc. stock logo
AGL
Agilon Health
-$0.01$0.03+$0.04$0.03$1.50 billion$1.53 billion
5/1/2025Q1 2025
Select Medical Holdings Corporation stock logo
SEM
Select Medical
$0.45$0.44-$0.01$0.44$1.40 billion$1.35 billion
4/24/2025Q1 2025
Encompass Health Corporation stock logo
EHC
Encompass Health
$1.19$1.37+$0.18$1.48$1.43 billion$1.46 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agilon Health, Inc. stock logo
AGL
Agilon Health
N/AN/AN/AN/AN/A
Encompass Health Corporation stock logo
EHC
Encompass Health
$0.680.56%N/A14.05%2 Years
Exelixis, Inc. stock logo
EXEL
Exelixis
N/AN/AN/AN/AN/A
Select Medical Holdings Corporation stock logo
SEM
Select Medical
$0.251.67%N/A18.66%N/A

Latest EHC, SEM, EXEL, and AGL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2025
Encompass Health Corporation stock logo
EHC
Encompass Health
quarterly$0.170.59%7/1/20257/1/20257/15/2025
5/1/2025
Select Medical Holdings Corporation stock logo
SEM
Select Medical
quarterly$0.06251.37%5/15/20255/15/20255/29/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilon Health, Inc. stock logo
AGL
Agilon Health
N/A
1.20
1.20
Encompass Health Corporation stock logo
EHC
Encompass Health
0.81
1.06
1.06
Exelixis, Inc. stock logo
EXEL
Exelixis
N/A
3.50
3.44
Select Medical Holdings Corporation stock logo
SEM
Select Medical
0.87
1.16
1.16

Institutional Ownership

CompanyInstitutional Ownership
Agilon Health, Inc. stock logo
AGL
Agilon Health
N/A
Encompass Health Corporation stock logo
EHC
Encompass Health
97.25%
Exelixis, Inc. stock logo
EXEL
Exelixis
85.27%
Select Medical Holdings Corporation stock logo
SEM
Select Medical
89.48%

Insider Ownership

CompanyInsider Ownership
Agilon Health, Inc. stock logo
AGL
Agilon Health
3.57%
Encompass Health Corporation stock logo
EHC
Encompass Health
2.00%
Exelixis, Inc. stock logo
EXEL
Exelixis
2.82%
Select Medical Holdings Corporation stock logo
SEM
Select Medical
11.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilon Health, Inc. stock logo
AGL
Agilon Health
1,076413.95 million399.17 millionNot Optionable
Encompass Health Corporation stock logo
EHC
Encompass Health
40,000100.80 million98.78 millionOptionable
Exelixis, Inc. stock logo
EXEL
Exelixis
1,147272.71 million265.02 millionOptionable
Select Medical Holdings Corporation stock logo
SEM
Select Medical
44,100128.54 million113.63 millionOptionable

Recent News About These Companies

Contrasting UnitedHealth Group (NYSE:UNH) & Select Medical (NYSE:SEM)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Agilon Health stock logo

Agilon Health NYSE:AGL

$2.32 +0.14 (+6.19%)
Closing price 06/26/2025 03:59 PM Eastern
Extended Trading
$2.29 -0.02 (-0.91%)
As of 06/26/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

Encompass Health stock logo

Encompass Health NYSE:EHC

$121.54 +0.87 (+0.72%)
Closing price 06/26/2025 03:59 PM Eastern
Extended Trading
$118.48 -3.06 (-2.52%)
As of 04:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

Exelixis stock logo

Exelixis NASDAQ:EXEL

$43.09 -0.44 (-1.01%)
Closing price 06/26/2025 04:00 PM Eastern
Extended Trading
$43.18 +0.09 (+0.22%)
As of 06/26/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat specific forms of advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. It develops zanzalintinib, a novel, potent, next-generation oral tyrosine kinase inhibitor (TKI) that targets VEGF receptors, MET and the TAM kinases (TYRO3, AXL and MER); and XB002, a next-generation tissue factor (TF)-targeting ADC, administered via intravenous infusion and composed of a human monoclonal antibody (mAb) against TF that is conjugated to an auristatin-based microtubulin inhibitor (MTI) payload. It has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited, as well as clinical development agreement with Sairopa B.V. for ADU-1805. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was incorporated in 1994 and is headquartered in Alameda, California.

Select Medical stock logo

Select Medical NYSE:SEM

$15.01 +0.10 (+0.69%)
Closing price 06/26/2025 03:59 PM Eastern
Extended Trading
$15.00 -0.01 (-0.05%)
As of 06/26/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. The Concentra segment operates and provides occupational health centers, telemedicine platforms, onsite clinics, and contract services at employer worksites that deliver occupational health services, consumer health, physical therapy, and preventive care. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.